Home » Topics » BioWorld Science

BioWorld Science
RSS

Bayer identifies new TANK1/2 inhibitors

June 1, 2018

Roche divulges gamma-secretase inhibitors

June 1, 2018

Merck & Co. patents alpha7 receptor PAMs

June 1, 2018

Transfusion reductions seen with stem cell gene therapy for beta-thalassemia

June 1, 2018

Shionogi and Hsiri collaborate to discover and develop new treatments for mycobacterial diseases

June 1, 2018

Amgen and M.D. Anderson enter two multiyear collaboration agreements

June 1, 2018

Mithra announces further positive phase IIb efficacy and safety results for Donesta

June 1, 2018

Astellas and FibroGen announce topline data from Japanese phase III study of roxadustat

June 1, 2018

Researchers identify GNMT as potential therapeutic target in UC and RCC

June 1, 2018

Nektar Therapeutics submits NDA to the FDA for NKTR-181

June 1, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...